Bombardieri E., Martinetti A., Miceli R., Mariani L., Castellani M.R., Seregni E.
Can
bone metabolism markers be adopted as an alternative to scintigraphic imaging in moni
toring bone metastases from breast cancer? // Eur. J. Nucl. Med. — 1997. — V. 24(11). —
P. 1349 1355.
Bonadonna G.
Evalution of adryamicin aloun and in combination in human neopla
sia // 8 th Int. Congr. Chemother. Atheus abstr. Vol. Bloomfield. — 1975. —¹ 4.
Bonarigo B.C., Rubin P.
Non union of pathological fracture after radiation therapy
// Radiology. — 1967. — V. 88. — P. 889 898.
Bonjour J.P., Philippe J., Guelpa G.
è ñîàâò. Bone and renal components in hyper
calcemia of malignancy and responses to a single infusion of clodronate // Bone. — 1988. —
V. 9. — P. 123 130.
Bonneterre J., Adenis A., Pion J.M., Cambier L., Kamus E., Hecquet B.
Aminoglutethimide (AG) and hydrocortisone (HC) in bone metastases: a retrospective
study // J. Steroid Biochem. Mol. Biol. — 1993. — V. 44(4 6). — P. 693 696.
Boissier S., Magnetto S., Frapppart L.,
è ñîàâò. Bisphosphonates inhibit prostate and
breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matri
ces // Cancer Res. — 1997. — V. 57 — P. 3890 3894.
Bouizar Z., Spyratos F., Deytieux S., de Vernejoul M.C., Jullienne A
. Polymerase
chain reaction analysis of parathyroid hormone related protein gene expression in breast
cancer patients and occurrence of bone metastases // Cancer Res. — 1993. — V. 53(21). —
P. 5076 5078.
Boyce B.F., Aufdemorte T.B., Garrett I.R., Yates A.J.P., Mundy G.R.
Effects of inter
leukin 1 on bone turnover in normal mice // Endocrinology. — 1989. — V. 125. —
P. 1142 1150.
Braun S., Pantel K., Janni W.
è ñîàâò. Cytokeratin positive bone marrow
micrometastases in stage I III breast cancer patients indicate poor prognosis independent
ly of lymph node metastasis // Program and abstracts of the 22nd SABC Symposium;
December 8 11. — 1999. — San Antonio, Texas. — Abstract 11.
Brenneis C.,
è ñîàâò. Local toxicity during the subcutaneous infusion on narcotics
(SCIN). A prospective study // Cancer Nurs. – 1987. — V. 10 (4). — P. 172 176.
Brenner D.E., Harvey H.A., Lipton A., Demers L.
A study of prostaglandin E2,
parathormone and response to indomethacin in patients with hypercalcaemia of malig
nancy // Cancer. — 1982. — V. 49. — P. 556 561.
Brodie A.M., Njar V.C.
Aromatase inhibitors and breast cancer // Semin. Oncol. –1996. —
V. 23. — P. 10 20.
Brown J.P., Delmas P.D., Malaval L., Edouard C., Chapuy M.C., Meunier P.J.
Serum bone GLA protein: a specific marker for bone formation in postmenopausal osteo
porosis // Lancet I. — 1984. — P.1091 1093.
Bruckman J.E., Bloomer W.D.
Managment of spinal cord compression // Sem.
Oncol — 1978. — V. 5. — P. 135.
Bruera E., Roca, Cedaro L.
è ñîàâò. Action of oral methilprednisolone in terminal
cancer patients: a prospective randomezid doube blinh study // Cancer Treat. Rep. —
1985. — V. 69. — P. 751 754.
Bruera E., Chadvick S., Brenneis C.,
è ñîàâò. Methylphenidate associated with nar
cotics for th treatment of cancer pain // Cancer Treatment Report. – 1987. — V. 71(1). —
P. 67 70.
Bruera E., Brenneis C., Michaud M.,
è ñîàâò. Use of the subcutaneous rout for the
administration of narcotic in patients with cancer pain // Cancer. — 1988. — V.62(2). —
P. 407 411.
218
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
